Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.

Jessen Krut J, Mellberg T, Price RW, Hagberg L, Fuchs D, Rosengren L, Nilsson S, Zetterberg H, Gisslén M.

PLoS One. 2014 Feb 11;9(2):e88591. doi: 10.1371/journal.pone.0088591. eCollection 2014.

PMID:
24523921
[PubMed - in process]
Free PMC Article
2.

Recognizing cognitive and psychiatric changes in the post-highly active antiretroviral therapy era.

Carvalhal A, Baril JG, Crouzat F, De Wet J, Junod P, Kovacs C, Sheehan N.

Can J Infect Dis Med Microbiol. 2012 Winter;23(4):209-15. Review.

PMID:
24294277
[PubMed]
Free PMC Article
3.

Test them all; an easily diagnosed and readily treatable cause of dementia with life-threatening consequences if missed.

Nightingale S, Michael BD, Defres S, Benjamin LA, Solomon T.

Pract Neurol. 2013 Dec;13(6):354-6. doi: 10.1136/practneurol-2013-000689. No abstract available.

PMID:
24222696
[PubMed - in process]
Free PMC Article
4.

Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale.

Cross S, Önen N, Gase A, Overton ET, Ances BM.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1114-22. doi: 10.1007/s11481-013-9505-1. Epub 2013 Oct 10.

PMID:
24114509
[PubMed - in process]
Free PMC Article
5.

Computational modeling reveals distinct effects of HIV and history of drug use on decision-making processes in women.

Vassileva J, Ahn WY, Weber KM, Busemeyer JR, Stout JC, Gonzalez R, Cohen MH.

PLoS One. 2013 Aug 7;8(8):e68962. doi: 10.1371/journal.pone.0068962. eCollection 2013. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/5a8e6fe0-623c-4d17-8781-9a0eadf67a43.

PMID:
23950880
[PubMed - in process]
Free PMC Article
6.

Tissue-specific HIV-1 infection: why it matters.

Karris MA, Smith DM.

Future Virol. 2011 Jul;6(7):869-882.

PMID:
23946764
[PubMed]
Free PMC Article
7.

Extracellular HIV-1 viral protein R affects astrocytic glyceraldehyde 3-phosphate dehydrogenase activity and neuronal survival.

Ferrucci A, Nonnemacher MR, Wigdahl B.

J Neurovirol. 2013 Jun;19(3):239-53. doi: 10.1007/s13365-013-0170-1. Epub 2013 Jun 1.

PMID:
23728617
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection.

Epstein AA, Narayanasamy P, Dash PK, High R, Bathena SP, Gorantla S, Poluektova LY, Alnouti Y, Gendelman HE, Boska MD.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1224-38. doi: 10.1007/s11481-013-9461-9. Epub 2013 May 24.

PMID:
23702663
[PubMed - in process]
Free PMC Article
9.

Neurocognitive function in HIV infected patients on antiretroviral therapy.

Winston A, Arenas-Pinto A, Stöhr W, Fisher M, Orkin CM, Aderogba K, De Burgh-Thomas A, O'Farrell N, Lacey CJ, Leen C, Dunn D, Paton NI; PIVOT Trial Team.

PLoS One. 2013 Apr 30;8(4):e61949. doi: 10.1371/journal.pone.0061949. Print 2013.

PMID:
23646111
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes.

Gray LR, Tachedjian G, Ellett AM, Roche MJ, Cheng WJ, Guillemin GJ, Brew BJ, Turville SG, Wesselingh SL, Gorry PR, Churchill MJ.

PLoS One. 2013 Apr 16;8(4):e62196. doi: 10.1371/journal.pone.0062196. Print 2013.

PMID:
23614033
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease.

Levine AJ, Miller JA, Shapshak P, Gelman B, Singer EJ, Hinkin CH, Commins D, Morgello S, Grant I, Horvath S.

BMC Med Genomics. 2013 Feb 13;6:4. doi: 10.1186/1755-8794-6-4.

PMID:
23406646
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons.

Crum-Cianflone NF, Moore DJ, Letendre S, Poehlman Roediger M, Eberly L, Weintrob A, Ganesan A, Johnson E, Del Rosario R, Agan BK, Hale BR.

Neurology. 2013 Jan 22;80(4):371-9. doi: 10.1212/WNL.0b013e31827f0776. Epub 2013 Jan 9.

PMID:
23303852
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons.

Andrade AS, Deutsch R, A Celano S, Duarte NA, Marcotte TD, Umlauf A, Atkinson JH, McCutchan JA, Franklin D, Alexander TJ, McArthur JC, Marra C, Grant I, Collier AC.

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):282-92. doi: 10.1097/QAI.0b013e31827ed678.

PMID:
23202813
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program.

Mind Exchange Working Group.

Clin Infect Dis. 2013 Apr;56(7):1004-17. doi: 10.1093/cid/cis975. Epub 2012 Nov 21.

PMID:
23175555
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration.

Croteau D, Rossi SS, Best BM, Capparelli E, Ellis RJ, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur J, McCutchan JA, Morgello S, Simpson DM, Grant I, Letendre S; CHARTER Group.

J Antimicrob Chemother. 2013 Mar;68(3):684-9. doi: 10.1093/jac/dks441. Epub 2012 Nov 9.

PMID:
23143899
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV.

Shikuma CM, Nakamoto B, Shiramizu B, Liang CY, DeGruttola V, Bennett K, Paul R, Kallianpur K, Chow D, Gavegnano C, Hurwitz SJ, Schinazi RF, Valcour VG.

Antivir Ther. 2012;17(7):1233-42. doi: 10.3851/IMP2411. Epub 2012 Sep 28.

PMID:
23018140
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study.

Joska JA, Westgarth-Taylor J, Hoare J, Thomas KG, Paul R, Myer L, Stein DJ.

BMC Infect Dis. 2012 Feb 15;12:39. doi: 10.1186/1471-2334-12-39.

PMID:
22335937
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Therapeutic amprenavir concentrations in cerebrospinal fluid.

Croteau D, Letendre S, Best BM, Rossi SS, Ellis RJ, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur J, McCutchan JA, Morgello S, Simpson DM, Way L, Capparelli E, Grant I; CHARTER Group.

Antimicrob Agents Chemother. 2012 Apr;56(4):1985-9. doi: 10.1128/AAC.05098-11. Epub 2012 Jan 30.

PMID:
22290964
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis.

Williams DW, Eugenin EA, Calderon TM, Berman JW.

J Leukoc Biol. 2012 Mar;91(3):401-15. doi: 10.1189/jlb.0811394. Epub 2012 Jan 6. Review.

PMID:
22227964
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Neurocognitive effects of HIV, hepatitis C, and substance use history.

Devlin KN, Gongvatana A, Clark US, Chasman JD, Westbrook ML, Tashima KT, Navia B, Cohen RA.

J Int Neuropsychol Soc. 2012 Jan;18(1):68-78. doi: 10.1017/S1355617711001408. Epub 2011 Dec 2.

PMID:
22132928
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk